Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus

6.1 The Committee noted contrasting outcomes in the available studies and was advised about the heterogeneous patient populations included in previous research.

6.2 The Committee noted that many patients presenting with squamous dysplasia of the oesophagus are frail and that other treatment options (including oesophagectomy and chemoradiotherapy) may be unsuitable or pose high risks for them.

6.3 The Committee noted that the risk of oesophageal strictures after endoscopic radiofrequency ablation is higher for squamous dysplasia than it is for Barrett's oesophagus with low‑grade dysplasia or no dysplasia, due to the nature of the underlying pathology.